A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain Injury.

Clinical trial NCT00735085 · TERMINATED

Trial details

NCT number: NCT00735085
Sponsor: Abbott Products
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Traumatic Brain Injury

Start date: 2009-04-01
Primary completion: 2010-08-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.